Key result
Intrahepatic injection of a hepatitis A virus deletion mutant RNA produced acute hepatitis in 2 marmosets within 3-4 weeks, indicating the pY1 sequence is not required for viral replication.
Why the study?
Does a hepatitis A virus deletion mutant lacking the first pyrimidine-rich tract of the 5' nontranslated RNA remain virulent and replicate in primates after intrahepatic RNA transfection?
Does a hepatitis A virus deletion mutant lacking the first pyrimidine-rich tract of the 5' nontranslated RNA remain virulent and replicate in primates after intrahepatic RNA transfection?
The pY1 sequence of HAV is not required for efficient viral replication in hepatocytes in situ or for production of acute hepatic injury in primates.
pY1 deletion preserves HAV virulence in marmosets; extends 5' NTR mapping but leaves open human relevance.
Cell culture-adapted variants of hepatitis A virus (HAV) in which the first pyrimidine-rich tract (pY1; nucleotides 99 to 138) of the 5' nontranslated region has been deleted (delta 96-137 or delta 96-139) replicate as well as parental virus in cultured cells (D.R. Shaffer, E.A. Brown, and S.M. Lemon, J. Virol. 68:5568-5578, 1994). To determine whether viruses with such large deletion mutations are able to replicate and to produce acute hepatitis in primates, we reconstructed the delta 96-137 deletion in the genetic background of a virulent virus which differs from the wild type by only one mutation in the 2B-coding region (HM175/8Y). Full-length synthetic delta 96-137/8Y RNA was injected into the livers of two HAV-seronegative marmosets (Saguinus mystax). Both animals developed serum liver enzyme elevations and inflammatory changes in serial liver biopsies within 3 to 4 weeks of inoculation which were comparable in magnitude to those observed previously following intrahepatic inoculation of marmosets with HM175/8Y RNA. Sequencing of RNA from virus shed in feces demonstrated the presence of the delta 96-137 deletion. These results indicate that the pY1 sequence of HAV is not required for efficient viral replication in hepatocytes in situ or for production of acute hepatic injury following intrahepatic RNA transfection in primates.
No takes yet. Share an insight, caveat, or question.
Shaffer et al. (1995) studied Hepatitis A virus infection (n=2). Intrahepatic injection of full-length synthetic delta 96-137/8Y RNA was evaluated on Serum liver enzyme elevations and inflammatory changes in serial liver biopsies. Intrahepatic injection of a hepatitis A virus deletion mutant RNA produced acute hepatitis in 2 marmosets within 3-4 weeks, indicating the pY1 sequence is not required for viral replication.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: